Geriatric population and Clinical trials ; Not enough attention given
US auditors observe that the attention given to geriatric population in clinical trials, safety studies is not up to the required level. This has been observed even in studies on diseases concerning mainly the elderly.
Bloomberg reports at Drug Trials Sometimes Exclude the Elderly, U.S. Auditors Say
Many drug trials exclude elderly participants, and others don't document a drug's safety and effectiveness for older people, according to the report issued today by the Government Accountability Office, the investigative agency of Congress.